Dr. Martens plc (LON:DOCS – Get Free Report)’s share price was down 1% during mid-day trading on Friday . The company traded as low as GBX 55.55 ($0.72) and last traded at GBX 56.10 ($0.73). Approximately 979,891 shares changed hands during mid-day trading, a decline of 54% from the average daily volume of 2,113,053 shares. The stock had previously closed at GBX 56.65 ($0.74).
Dr. Martens Stock Performance
The stock’s 50-day moving average price is GBX 58.22 and its 200-day moving average price is GBX 70.20. The company has a market capitalization of £539.52 million, a price-to-earnings ratio of 801.43, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85.
Insiders Place Their Bets
In other Dr. Martens news, insider Kenny Wilson bought 30,000 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was purchased at an average cost of GBX 55 ($0.72) per share, for a total transaction of £16,500 ($21,478.78). In related news, insider Lynne Weedall acquired 25,000 shares of Dr. Martens stock in a transaction dated Tuesday, August 27th. The shares were acquired at an average cost of GBX 74 ($0.96) per share, for a total transaction of £18,500 ($24,082.27). Also, insider Kenny Wilson acquired 30,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The shares were bought at an average price of GBX 55 ($0.72) per share, with a total value of £16,500 ($21,478.78). Over the last ninety days, insiders have bought 113,446 shares of company stock worth $6,542,582. 4.36% of the stock is owned by corporate insiders.
About Dr. Martens
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than Dr. Martens
- When to Sell a Stock for Profit or Loss
- California Resources Stock Could Be a Huge Long-Term Winner
- Canadian Penny Stocks: Can They Make You Rich?
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Why Invest in 5G? How to Invest in 5G Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.